Clinical Trial Update: Buprenorphine and Naloxone Combination Study - 10 [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 clinical trial evaluating a buprenorphine/naloxone combination for heroin dependence and opioid use disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence, Opioid-Related Disorders | Phase 1 | Status: COMPLETED